Med Tech-related technology assessments from NICE in February 2025

The National Institute for Health and Care Excellence (NICE) develops Interventional Procedures Guidance (IPG) for most novel interventional procedures entering the English market. The program focuses solely on clinical evidence. Recommendations may vary from "for research only" to "for use with standard arrangements for clinical governance, consent, and audit." Recommendations are not binding, although they are followed by providers and commissioners.

In February 2025, NICE published one new IPG on Intravascular lithotripsy to treat calcified coronary arteries during percutaneous coronary intervention and recommended the procedure for use in the NHS with standard arrangements for clinical governance, consent, and audit. NICE concluded that there is good-quality evidence of the procedure's effectiveness and safety. The evidence shows that calcification is reduced, and blood vessel diameter is increased after this procedure, meaning a stent can be more easily inserted. People having this procedure already have a high risk of cardiovascular complications, but there is no evidence that intravascular lithotripsy increases this risk. This procedure is widely used and established in clinical practice.

Furthermore, in February 2025, NICE updated one clinical guideline on Advanced breast cancer: diagnosis and treatment.

See the full details here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.